Affymetrix (Santa Clara, California) (AFFX) Introduces New Axiom® 384HT Genotyping Format Enabling New Level of Cost-Effective, High-Throughput Genotyping Studies
7/29/2013 10:19:50 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analyzing up to 50,000 SNPs per sample. '
The array content of the new Axiom 384HT format is fully customizable, supporting applications ranging from detailed assessment of human disease to high-throughput agricultural screening and marker-assisted breeding. This new 384-array format runs seamlessly on the existing GeneTitan® Multichannel Instrument, providing researchers with a flexible choice of array formats on a single automated platform for highly cost-effective identification, validation, and screening of complex genetic traits.
Help employers find you! Check out all the jobs and post your resume.